Abiomed Inc
ABMDDelisted Dec 22, 2022- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000815094
Abiomed Inc was delisted on Dec 22, 2022; its insiders filed their last Form 4 on Dec 27, 2022; 516 institutions reported holding it in 13F filings for Q3 2022, worth $10.6B in total; Maverick Capital was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Abiomed Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 516 | 10 | 9 | −497 |
| Shares | 43.1M | 138.1K | 14.0K | −42.9M (−100.0%) |
| Value | $10.6B | $33.9M | $4.62M | −$10.5B (−100.0%) |
10 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Abiomed Inc at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (497)
Institutions that held Abiomed Inc at the end of Q3 2022 and filed for Q4 2022 without it.
Showing the largest 100 of 497 by value.
Not filed for Q4 2022 yet (10)
Institutions that held Abiomed Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Eaton Vance Management | 126,759 | $31.1M |
| Corient Capital Partners, LLC | 5,298 | $1.31M |
| Keebeck Alpha, LP | 1,368 | $336.0K |
| 17 Capital Partners, LLC | 1,145 | $281.0K |
| Redpoint Investment Management Pty Ltd | 1,106 | $272.0K |
| Bluestein R H & Co | 1,025 | $252.0K |
| American Portfolios Advisors | 691 | $169.8K |
| Wipfli Financial Advisors LLC, | 378 | $93.0K |
| FourThought Financial, LLC | 298 | $73.0K |
| Covington Capital Management | 6 | $1.00K |